The autophagy-inhibitory tissue hormone DBI/ACBP contributes to the pathogenesis of multiple organ dysfunction

Flavia Lambertucci1, Maria Chiara Maiuri1,2, Isabelle Martins1

  • 1Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, Team « Metabolism, Cancer & Immunity », Equipe labellisée par la Ligue contre le cancer, Paris, France.

Autophagy
|June 2, 2026
PubMed

Insights

Elevated acyl-CoA binding protein (ACBP), encoded by the diazepam binding inhibitor (DBI) gene, exacerbates septic shock and multiple organ dysfunction syndrome (MODS). Neutralizing DBI/ACBP significantly reduced mortality and alleviated MODS in preclinical models.

Area of Science:

  • Immunology
  • Pathophysiology
  • Molecular Medicine

Background:

  • Septic shock and multiple organ dysfunction syndrome (MODS) are leading causes of mortality with limited treatment options.
  • Acyl-CoA binding protein (ACBP), encoded by the diazepam binding inhibitor (DBI) gene, is a tissue hormone that inhibits autophagy.
  • Elevated circulating DBI/ACBP levels are observed in patients with septic shock and correlate with disease severity.

Purpose of the Study:

  • To investigate the role of DBI/ACBP in sepsis pathophysiology.
  • To evaluate the therapeutic potential of DBI/ACBP neutralization in preclinical sepsis models.

Main Methods:

  • DBI/ACBP levels were measured in patients and mouse models of sepsis.
  • Monoclonal antibodies were used to neutralize DBI/ACBP in mouse models.
  • Comprehensive phenotyping and multi-omics analyses were performed.
  • In vitro and in vivo assays assessed the impact of DBI/ACBP inhibition on inflammation and bacterial clearance.

Main Results:

  • DBI/ACBP concentrations were significantly elevated in septic shock patients and mouse models.
  • Neutralization of DBI/ACBP reduced mortality and alleviated MODS hallmarks in mice.
  • DBI/ACBP inhibition attenuated sepsis-associated molecular and cellular changes.
  • DBI/ACBP inhibition enhanced organ resistance to inflammation and promoted bacterial clearance.

Conclusions:

  • DBI/ACBP is a pathogenic mediator of sepsis and MODS.
  • Neutralizing DBI/ACBP represents a promising therapeutic strategy for sepsis.

Related Concept Videos

Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...